Glaucoma drugs and ocular-hypertension meds face shortages

Monday, 16 February 2026AI summary
Glaucoma drugs and ocular-hypertension meds face shortages
Photo: Correio da Manhã

Correio da Manhã and Observador report supply difficulties affecting medications for glaucoma and ocular hypertension, with authorities allowing temporary substitution of package types in already issued prescriptions. Pharmacies and prescribers may swap equivalent presentations to keep patients supplied while shortages persist, according to the coverage. Patients who use these eye medicines should check with their pharmacy or GP about substitutions and ensure they keep follow-up appointments for monitoring. Those with glaucoma or ocular hypertension should confirm continuity plans with their clinic or pharmacist.

Update: Two glaucoma medicines reported affected

Observador says two specific medicines for glaucoma and ocular hypertension are facing supply problems; pharmacies continue to rely on permitted substitutions of equivalent presentations to avoid treatment gaps while shortages continue.

Context & Explainers

Glaucoma is a group of eye conditions that damage the optic nerve, usually associated with raised pressure inside the eye, and can cause irreversible vision loss if untreated. It is a chronic condition managed with pressure‑lowering eye drops, laser therapy, or surgery, so patients should check with their ophthalmologist or pharmacist if prescription substitutions are temporarily allowed.

Ocular hypertension means the pressure inside the eye (intraocular pressure) is higher than normal—typically above about 21 mmHg—without detectable optic nerve damage or visual field loss. It is a risk factor for glaucoma, so doctors usually monitor it regularly and may start treatment to lower pressure if the risk of progression is judged significant.

Sources (2)

Continue reading